Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IBI362 in Chinese overweight and obese subjects
NCT04904913Phase 2Completed
- Sponsor
- Innovent Biologics
- Start
- Jun 2021
- Primary completion
- Mar 2023
- Modality
- Hormonal Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of mazdutide in obesity, sponsored by Innovent Biologics. Started Jun 2021; status: completed.
02
Drugs
mazdutide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT04904913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04904913.